News headlines about CIGNA (NYSE:CI) have trended positive on Saturday, Alpha One reports. Alpha One, a subsidiary of Accern, ranks the sentiment of press coverage by analyzing more than twenty million news and blog sources in real time. Alpha One ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. CIGNA earned a news impact score of 0.29 on Alpha One’s scale. Alpha One also assigned news stories about the health services provider an impact score of 82 out of 100, indicating that recent press coverage is very likely to have an effect on the company’s share price in the next several days.
Here are some of the news stories that may have impacted Alpha One’s analysis:
- CIGNA Co. (CI) EVP Sells $3,250,732.48 in Stock (americanbankingnews.com)
- Tag: CIGNA (dougleschan.com)
- The CIGNA Co. Forecasted to Earn Q2 2017 Earnings of $2.46 Per Share (CI) – BangaloreWeekly (bangaloreweekly.com)
- The CIGNA Co. (CI) Given Consensus Recommendation of “Buy” by Brokerages – BangaloreWeekly (bangaloreweekly.com)
- The Checchi Capital Advisers LLC Boosts Position in CIGNA Co. (CI) – BangaloreWeekly (bangaloreweekly.com)
Several brokerages recently commented on CI. Royal Bank of Canada upped their price target on shares of CIGNA from $172.00 to $177.00 and gave the company an “outperform” rating in a report on Monday, May 15th. Stifel Nicolaus upped their target price on shares of CIGNA from $170.00 to $175.00 and gave the stock a “buy” rating in a research note on Monday, May 15th. Deutsche Bank AG upped their target price on shares of CIGNA from $172.00 to $175.00 and gave the stock a “buy” rating in a research note on Wednesday, May 10th. Jefferies Group LLC upped their target price on shares of CIGNA from $178.00 to $183.00 and gave the stock a “buy” rating in a research note on Monday, May 15th. Finally, Zacks Investment Research upgraded shares of CIGNA from a “sell” rating to a “hold” rating in a research note on Tuesday, April 11th. Three analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $167.57.
CIGNA (NYSE:CI) opened at 159.48 on Friday. The firm’s 50-day moving average is $155.86 and its 200-day moving average is $145.54. CIGNA has a 52 week low of $115.03 and a 52 week high of $164.88. The firm has a market cap of $40.83 billion, a price-to-earnings ratio of 21.29 and a beta of 0.53.
CIGNA (NYSE:CI) last released its quarterly earnings results on Friday, May 5th. The health services provider reported $2.77 earnings per share for the quarter, topping analysts’ consensus estimates of $2.44 by $0.33. CIGNA had a net margin of 4.71% and a return on equity of 15.77%. The business had revenue of $10.39 billion during the quarter, compared to the consensus estimate of $10.11 billion. During the same quarter last year, the company earned $2.46 earnings per share. The business’s quarterly revenue was up 5.1% compared to the same quarter last year. On average, equities analysts anticipate that CIGNA will post $9.63 earnings per share for the current year.
In related news, CFO Thomas A. Mccarthy sold 4,464 shares of the firm’s stock in a transaction on Monday, February 27th. The stock was sold at an average price of $146.54, for a total transaction of $654,154.56. Following the transaction, the chief financial officer now directly owns 80,531 shares in the company, valued at $11,801,012.74. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO David Cordani sold 43,637 shares of the firm’s stock in a transaction on Monday, February 27th. The stock was sold at an average price of $147.78, for a total value of $6,448,675.86. Following the transaction, the chief executive officer now owns 306,194 shares in the company, valued at $45,249,349.32. The disclosure for this sale can be found here. Insiders have sold 81,535 shares of company stock valued at $12,305,734 in the last three months. Corporate insiders own 1.20% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “CIGNA (CI) Earns News Impact Rating of 0.29” was first posted by Transcript Daily and is the property of of Transcript Daily. If you are reading this story on another domain, it was illegally stolen and reposted in violation of United States and international copyright legislation. The correct version of this story can be accessed at https://transcriptdaily.com/2017/05/20/favorable-media-coverage-very-likely-to-affect-cigna-ci-share-price-updated-updated-updated.html.
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Receive News & Ratings for CIGNA Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA Co. and related companies with MarketBeat.com's FREE daily email newsletter.